Solubility enhancement of celecoxib using solidified Tween 80 for the formulation of tablet dosage forms
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chakma, S. | - |
dc.contributor.author | Khadka, P. | - |
dc.contributor.author | Jo, K. | - |
dc.contributor.author | Kim, H. | - |
dc.contributor.author | Ro, J. | - |
dc.contributor.author | Park, K. | - |
dc.contributor.author | Karki, S. | - |
dc.contributor.author | Barua, S. | - |
dc.contributor.author | Lee, J. | - |
dc.date.available | 2019-03-08T20:37:19Z | - |
dc.date.issued | 2015-10-22 | - |
dc.identifier.issn | 2093-5552 | - |
dc.identifier.issn | 2093-6214 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/11341 | - |
dc.description.abstract | Celecoxib is a non-steroidal, anti-inflammatory drug used in the treatment of pain and inflammation associated with rheumatoid arthritis, and several other inflammatory disorders. It is a class II compound according to the Biopharmaceutics Classification System owing to its low water solubility and high membrane permeability. The objective of this study was to improve the solubility and dissolution rate of celecoxib using solid surfactant technology that might be useful in developing solid dosage forms. Solid surfactant was developed by mixing and grinding together a liquid surfactant (Tween 80) with various inorganic carriers like Fujicalin® (Dibasic Calcium Phosphate Anhydrous), Pineflow® (Porous-structured Maltodextrin), Neusilin® (Magnesium Alumino metasilicate) and Aerosil® (Colloidal Silicon dioxide) in a mortar and pestle in different ratios of liquid surfactant and the carrier to obtain solid surfactants. The celecoxib tablets prepared with solid surfactants were then evaluated for their solubility and dissolution properties. Among the fillers used, Fujicalin showed the highest solubilization capacity for celecoxib. The dissolution behaviors of various tablets prepared with solidified surfactants were compared to those of conventional celecoxib tablets in a simulated gastric fluid. Celecoxib tablets prepared using solidified surfactants showed improved dissolution behaviors when compared to the conventional counterparts. Fujicalin solidified Tween 80 was further analyzed by powder X-ray diffraction analysis, differential scanning calorimetry thermographs and reverse phase high performance liquid chromatography. © 2015, The Korean Society of Pharmaceutical Sciences and Technology. | - |
dc.format.extent | 12 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Kluwer Academic Publishers | - |
dc.title | Solubility enhancement of celecoxib using solidified Tween 80 for the formulation of tablet dosage forms | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/s40005-015-0192-1 | - |
dc.identifier.bibliographicCitation | Journal of Pharmaceutical Investigation, v.45, no.5, pp 449 - 460 | - |
dc.identifier.kciid | ART002040841 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-84941960835 | - |
dc.citation.endPage | 460 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 449 | - |
dc.citation.title | Journal of Pharmaceutical Investigation | - |
dc.citation.volume | 45 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Celecoxib | - |
dc.subject.keywordAuthor | Fujicalin | - |
dc.subject.keywordAuthor | Solidified Tween 80 | - |
dc.subject.keywordAuthor | Solubility enhancement | - |
dc.subject.keywordAuthor | Water insoluble drug | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.